Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 2/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29027777 | 1.00 | NAAA (0.53) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL26415654 | 0.96 | NAAA (0.53) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL5860691 | 0.92 | NAAA (0.53) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL3640964 | 0.92 | CNR1 (0.47) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL1940161 | 0.92 | CASP2 (0.54) | NAAADNM1CASP2FAAHSLC6A5 | |
| SCHEMBL13402876 | 0.92 | NAAA (0.61) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL14984045 | 0.92 | NAAA (0.61) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL29833826 | 0.92 | NAAA (0.61) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL25447807 | 0.92 | NAAA (0.61) | NAAACNR1DNM1CASP2FAAH | |
| SCHEMBL15006922 | 0.92 | NAAA (0.61) | NAAACNR1DNM1CASP2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023016999-A2 | Compounds | Cargene Therapeutics Pte. Ltd. (SG) | 2023-02-16 | — | — | WO | disclosed |